Coroldo1 Profile picture
Feb 26, 2021 62 tweets 51 min read Read on X
#CHINACDC #SHANGHAICDC #IVDC #COMPANIES #SARSCoV2
This thread tends to give background historical information regarding authors of the first genomes and their own/affiliated private companies which benefit from outbreaks over ten year prior to covid-19.
#CHINACDC #CPAM Business driven mainly under the cover of this CPAM.
1/3 Image
Image
Image
Image
#CHINACDC Business driven mainly under the cover of this CPAM.
2/3 Image
Image
Image
Image
#CHINACDC Business driven mainly under the cover of this CPAM.
3/3 Image
Image
Image
#CHINACDC #COMPANIES #XABT Xujun Ma and Wenbo Xu promoted the X-ABT kit developed by his team.
1/5 Image
Image
Image
Image
#CHINACDC #COMPANIES #XABT Xujun Ma and Wenbo Xu promoted the X-ABT kit developed by his team.
2/5 Image
Image
Image
Image
#CHINACDC #COMPANIES #XABT Xujun Ma and Wenbo Xu promoted the X-ABT kit developed by his team.
3/5 Image
Image
Image
Image
#CHINACDC #COMPANIES #XABT Xujun Ma and Wenbo Xu promoted the X-ABT kit developed by his team.
4/5 Image
Image
Image
Image
#CHINACDC #COMPANIES #XABT Xujun Ma and Wenbo Xu promoted the X-ABT kit developed by his team.
5/5 Image
Image
Image
#CHINACDC #COMPANNIES Wenbo Xu et al, deliberatedly ignored the acknowledgement of the origin of their technology in publications, TSP developed by Australian scientists.
When challenged by the Australian scientist regarding their PLOS one publication....
1/3 Image
Image
Image
Image
#CHINACDC #IVDC Wenbo Xu oblidged to issued a correction, but never mention the initial source of the tech in their application for national reward. Cheat,steal,lie.
2/3 Image
#CHINACDC #COMPANIES #XABT a bit of history of this notorious China CDC company, X-ABT, former Beijing Ortirus, controlled by Zhiqiang Zhang. 1/2 Image
Image
Image
Image
#CHINACDC #COMPANIES #XABT a bit of history of this notorious China CDC company, X-ABT, former Beijing Ortirus, controlled by Zhiqiang Zhang. 2/2 Image
Image
#CHINACDC #IVDC #XABT Wenbo Xu, Xuejun Ma ey al, used TSP technology developed kits and their affiliated private company, applied and won innovation tech prize. 1/34 Image
Image
Image
Image
#CHINACDC #IVDC #XABT Wenbo Xu, Xuejun Ma ey al, used TSP technology developed kits and their affiliated private company, applied and won innovation tech prize. 2/34 Image
Image
Image
Image
#CHINACDC #IVDC #XABT Wenbo Xu, Xuejun Ma ey al, used TSP technology developed kits and their affiliated private company, applied and won innovation tech prize. 3/34 Image
Image
Image
Image
#CHINACDC #IVDC #XABT Wenbo Xu, Xuejun Ma ey al, used TSP technology developed kits and their affiliated private company, applied and won innovation tech prize. 4/34 Image
Image
Image
Image
#CHINACDC #IVDC #XABT Wenbo Xu, Xuejun Ma ey al, used TSP technology developed kits and their affiliated private company, applied and won innovation tech prize. 5/34 Image
Image
Image
Image
#CHINACDC #IVDC #XABT Wenbo Xu, Xuejun Ma ey al, used TSP technology developed kits and their affiliated private company, applied and won innovation tech prize. 6/34 Image
Image
Image
Image
#CHINACDC #IVDC #XABT Wenbo Xu, Xuejun Ma ey al, used TSP technology developed kits and their affiliated private company, applied and won innovation tech prize. 7/34 Image
Image
Image
Image
#CHINACDC #IVDC #XABT Wenbo Xu, Xuejun Ma ey al, used TSP technology developed kits and their affiliated private company, applied and won innovation tech prize. 8/34 Image
Image
Image
Image
#CHINACDC #IVDC #XABT Wenbo Xu, Xuejun Ma ey al, used TSP technology developed kits and their affiliated private company, applied and won innovation tech prize. 9/34 Image
Image
Image
Image
#CHINACDC #IVDC #XABT Wenbo Xu, Xuejun Ma ey al, used TSP technology developed kits and their affiliated private company, applied and won innovation tech prize. 10/34 Image
Image
Image
Image
#CHINACDC #IVDC #XABT Wenbo Xu, Xuejun Ma ey al, used TSP technology developed kits and their affiliated private company, applied and won innovation tech prize. 11/34 Image
Image
Image
Image
#CHINACDC #IVDC #XABT Wenbo Xu, Xuejun Ma ey al, used TSP technology developed kits and their affiliated private company, applied and won innovation tech prize. 12/34 Image
Image
Image
Image
#CHINACDC #IVDC #XABT Wenbo Xu, Xuejun Ma ey al, used TSP technology developed kits and their affiliated private company, applied and won innovation tech prize. 13/34 Image
Image
Image
Image
#CHINACDC #IVDC #XABT Wenbo Xu, Xuejun Ma ey al, used TSP technology developed kits and their affiliated private company, applied and won innovation tech prize. 14/34 Image
Image
Image
Image
#CHINACDC #IVDC #XABT Wenbo Xu, Xuejun Ma ey al, used TSP technology developed kits and their affiliated private company, applied and won innovation tech prize. 15/34 Image
Image
Image
Image
#CHINACDC #IVDC #XABT Wenbo Xu, Xuejun Ma ey al, used TSP technology developed kits and their affiliated private company, applied and won innovation tech prize. 16/34 Image
Image
Image
Image
#CHINACDC #IVDC #XABT Wenbo Xu, Xuejun Ma ey al, used TSP technology developed kits and their affiliated private company, applied and won innovation tech prize. 17/34 Image
Image
Image
Image
#CHINACDC #IVDC #XABT Wenbo Xu, Xuejun Ma ey al, used TSP technology developed kits and their affiliated private company, applied and won innovation tech prize. 18/34 Image
Image
Image
Image
#CHINACDC #IVDC #XABT Wenbo Xu, Xuejun Ma ey al, used TSP technology developed kits and their affiliated private company, applied and won innovation tech prize. 19/34 Image
Image
Image
Image
#CHINACDC #IVDC #XABT Wenbo Xu, Xuejun Ma ey al, used TSP technology developed kits and their affiliated private company, applied and won innovation tech prize. 20/34 Image
Image
Image
Image
#CHINACDC #IVDC #XABT Wenbo Xu, Xuejun Ma ey al, used TSP technology developed kits and their affiliated private company, applied and won innovation tech prize. 21/34 Image
Image
Image
Image
#CHINACDC #IVDC #XABT Wenbo Xu, Xuejun Ma ey al, used TSP technology developed kits and their affiliated private company, applied and won innovation tech prize. 22/34 Image
Image
Image
Image
#CHINACDC #IVDC #XABT Wenbo Xu, Xuejun Ma ey al, used TSP technology developed kits and their affiliated private company, applied and won innovation tech prize. 23/34 Image
Image
Image
Image
#CHINACDC #IVDC #XABT Wenbo Xu, Xuejun Ma ey al, used TSP technology developed kits and their affiliated private company, applied and won innovation tech prize. 24/34 Image
Image
Image
Image
#CHINACDC #IVDC #XABT Wenbo Xu, Xuejun Ma ey al, used TSP technology developed kits and their affiliated private company, applied and won innovation tech prize. 25/34 Image
Image
Image
Image
#CHINACDC #IVDC #XABT Wenbo Xu, Xuejun Ma ey al, used TSP technology developed kits and their affiliated private company, applied and won innovation tech prize. 26/34 Image
Image
Image
Image
#CHINACDC #IVDC #XABT Wenbo Xu, Xuejun Ma ey al, used TSP technology developed kits and their affiliated private company, applied and won innovation tech prize. 27/34 Image
Image
Image
Image
#CHINACDC #IVDC #XABT Wenbo Xu, Xuejun Ma ey al, used TSP technology developed kits and their affiliated private company, applied and won innovation tech prize. 28/34 Image
Image
Image
Image
#CHINACDC #IVDC #XABT Wenbo Xu, Xuejun Ma ey al, used TSP technology developed kits and their affiliated private company, applied and won innovation tech prize. 29/34 Image
Image
Image
Image
30/34 Image
Image
Image
Image
31/34 Image
Image
Image
Image
32/34 Image
Image
Image
Image
33/34 Image
Image
Image
Image
34/34 Image
Image
#CHINACDC #IVDC Wenbo Xu oblidged to issued a correction, but never mention the initial source of the tech in their application for national reward.3/3 Image
Image
Image
Image
#CHINACDC #MDx #PATHOGEN #IVDC Under the name of training workshop, (Wenbo Xu & Xuejun Ma et al) manage to designate the meeting between public servants and private companies from 2015, started from Ma's hometown, Hunan.
1/9 Image
Image
Image
Image
#CHINACDC #MDx #PATHOGEN #IVDC Under the name of training workshop, (Wenbo Xu & Xuejun Ma et al) manage to designate the meeting between public servants and private companies from 2015, started from Ma's hometown, Hunan.
2/9 Image
Image
Image
Image
#CHINACDC #MDx #PATHOGEN #IVDC Under the name of training workshop, (Wenbo Xu & Xuejun Ma et al) manage to designate the meeting between public servants and private companies from 2015, started from Ma's hometown, Hunan.
3/9 Image
Image
Image
Image
#CHINACDC #MDx #PATHOGEN #IVDC Under the name of training workshop, (Wenbo Xu & Xuejun Ma et al) manage to designate the meeting between public servants and private companies from 2015, started from Ma's hometown, Hunan.
4/9 Image
Image
Image
Image
#CHINACDC #MDx #PATHOGEN #IVDC Under the name of training workshop, (Wenbo Xu & Xuejun Ma et al) manage to designate the meeting between public servants and private companies from 2015, started from Ma's hometown, Hunan.
5/9 Image
Image
Image
Image
#CHINACDC #MDx #PATHOGEN #IVDC Under the name of training workshop, (Wenbo Xu & Xuejun Ma et al) manage to designate the meeting between public servants and private companies from 2015, started from Ma's hometown, Hunan.
6/9 Image
Image
Image
Image
#CHINACDC #CNIC Xiang Zhao, the author of first 3 SARS-COV-2 genomes of IVDC in GISAID, also many other papers. Started his own secret company in 2012, made home-brew kits in CNIC lab, then sell back to CNIC and CDCs all over the country via his company, 1/2 Image
Image
Image
#CHINACDC #CNIC funneling national funding into own pockets. Together with him, members of CNIC and one later become key member of Shanghai Bio-germ 2/2 bio-germ.comImage
Image
Image
Image
Unroll coroldo1 @threadreaderapp
Unroll coroldo1 @buzz_chronicles
Unroll coroldo1 @threadreaderapp
Unroll coroldo1 @buzz_chronicles
#CHINACDC #COMPANIES #XABT Wenbo Xu’s role in IVDC and commercial activities regulations, seems impossible to prevent potential conflict of public&private interest.
1/4 Image
Image
Image
Image
#CHINACDC #COMPANIES #XABT Wenbo Xu’s role in IVDC and commercial activities regulations, seems impossible to prevent potential conflict of public&private interest.
2/4 Image
Image
Image
Image
#CHINACDC #COMPANIES #XABT Wenbo Xu’s role in IVDC and commercial activities regulations, seems impossible to prevent potential conflict of public&private interest.
3/4 Image
Image
Image
Image
#CHINACDC #COMPANIES #XABT Wenbo Xu’s role in IVDC and commercial activities regulations, seems impossible to prevent potential conflict of public&private interest.
4/4 Image

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Coroldo1

Coroldo1 Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @coroldo1

May 3, 2024
An article full of mistakes.
1. A commercial NGS company, Visionmedical, first sequenced and assembled full genome of this bat-like beta coronavirus from sample of a unknown pneumonia patient in Wuhan, before 2020.
2. The 'rectification' was a result of a normal and yearly CNAS biosaftey inspection, btn 3rd-5th Jan 2020, an expert team of 5 did a full inspection, evaluated the emergency response of SHPHCC BSL-3 lab. After inspection, expert team listed 8 issues, suggested rectifications
according to CNAS regulations asap.
In comparison, a CNAS expert team of 4 listed 7 issues and suggested rectifications according to CNAS regulations, in the biosafety inspection in year 2018.
Both above were posted on SHPHCC website news section with timestamp and photos.
Read 15 tweets
May 1, 2024
来,帮主吃瓜
@paibangzhu


Image
Image
Image
Image
Image
Absolutely GOLD to watch the usual participants and media launched campaign again repeating March 2023.
Absolutely shame to use 8 young students' future as human shield to spark this nonsense, nobody actually cares abt these young students, whom weren't even enrolled in 2020.
Read 33 tweets
Mar 31, 2023
@martinenserink
The snapshots contain rich information.
1. 'it is a novel coronavirus' = distinctive from SARS1, must have been successfully isolated from patient samples, must have been verified (revisit the *chlamydia* in SARS1)
@martinenserink 2. W/o knowing the exact contents, based on the low resolution image and file name of the pptx, predated Virological. That alone, already can be treated as a high confidence evidence that China, through GISAID, was providing a unique additional info regarding the novel cov to WHO
@martinenserink 3. By a glance of the low resolution image of pptx, a possible standard NJ tree of ORF1b. Normally, considering the file size, one page ppt would incl the details of tree creation, against CoV family or particular strains, and *source(s)* of the colour highlighten genomes.
Read 48 tweets
Mar 29, 2023
chinaxiv.org/abs/202303.103…
Would love to have a comparison of June 2022 revision and today's new release on ChinaXiv.
If available. So, pls, that 'reviewer who claims to have reviewed the manuscript for Nature'.
I am not caring too much for the conclusion part, as this new version seems targeting for expedited peer-review process. We all see 'toned down' with previous preprints vs publications.
What's important was the comparison of results in those versions.

If the June 2022 vs ChinaXiv, not much difference, and new version get published. Then, I think not CCDC but someone else get explanation to do.
Read 7 tweets
Mar 28, 2023
Is it an established fact that no one on twitter or press seem bother emphasising? that:
1. In SAGO meeting, the original data generators said they already *KNEW* the raccoon dogs etc al sequence in the data they produced (before lifted embargo) , and was in the middle of
submitting a revision.
2. The coauthor(obviously not the communication authors with email listed and mobile number too well known to *everyone*) of both preprint and initial illumina data& BGI data, expressed during the initial contact, that(pls pay attention)
*we were told to release the data....feel free to analyse....happy to answer any questions... *.
Read 5 tweets
Mar 27, 2023
A brief 'announcement'.😹 Busy with something more important, just break in briefly.
1. Pls, don't want to reply to the DMs flooded in, until we see the origonal data generators' own publication.
2. Accuracy...... If we want to avoid accusations of *power of media*, perhaps anyone point to me the reference of this specific usage implied transferring live animals, 'In one sample from a cart used to move cages', as if the reporter was there......
nature.com/articles/d4158…
3. I *strongly believed* that the original environmental sampling documents and records were written in *Chinese*, no? Why not?
So, if u googled 脱毛机, isn't human epilators all over ur screen? I knew it's hard for some male reviewer #3 to comprehend🤭.

Read 7 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(